Literature DB >> 17040620

Molecular genetics of pediatric central nervous system tumors.

Nicole J Ullrich1, Scott L Pomeroy.   

Abstract

Recent advances in molecular biology have enhanced our understanding of the pathogenesis of brain tumors, particularly in children. The use of molecular diagnostic tools is quickly becoming a standard component in the diagnosis and classification of brain tumors in children, in addition to providing insight leading to treatment stratification and improved outcome prediction. All new protocols involving treatments for brain tumors in children include studies of biomarkers and biologic correlates as a means to identify new targets for therapeutics and possible intervention strategies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17040620     DOI: 10.1007/s11912-006-0070-0

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  55 in total

1.  Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations.

Authors:  N Sévenet; A Lellouch-Tubiana; D Schofield; K Hoang-Xuan; M Gessler; D Birnbaum; C Jeanpierre; A Jouvet; O Delattre
Journal:  Hum Mol Genet       Date:  1999-12       Impact factor: 6.150

2.  Chromosomal imbalances in clear cell ependymomas.

Authors:  Christian H Rickert; Andrey Korshunov; Werner Paulus
Journal:  Mod Pathol       Date:  2006-04-28       Impact factor: 7.842

3.  Characterisation of X;17(q12;p13) translocation breakpoints in a female patient with hypomelanosis of Ito and choroid plexus papilloma.

Authors:  V Zajac; T Kirchhoff; E R Levy; S W Horsley; A Miller; E Steichen-Gersdorf; A P Monaco
Journal:  Eur J Hum Genet       Date:  1997 Mar-Apr       Impact factor: 4.246

4.  Identification of five new families strengthens the link between childhood choroid plexus carcinoma and germline TP53 mutations.

Authors:  Vera Krutilkova; Marie Trkova; Julie Fleitz; Vladimir Gregor; Kamila Novotna; Anna Krepelova; David Sumerauer; Roman Kodet; Simona Siruckova; Pavlina Plevova; Sarka Bendova; Petra Hedvicakova; Nicholas K Foreman; Zdenek Sedlacek
Journal:  Eur J Cancer       Date:  2005-07       Impact factor: 9.162

Review 5.  Atypical teratoid/rhabdoid tumors of the central nervous system.

Authors:  Alyssa T Reddy
Journal:  J Neurooncol       Date:  2005-12       Impact factor: 4.130

6.  An analysis of SEER data of increasing risk of secondary malignant neoplasms among long-term survivors of childhood brain tumors.

Authors:  Katia M Peterson; Cheng Shao; Robert McCarter; Tobey J MacDonald; Julianne Byrne
Journal:  Pediatr Blood Cancer       Date:  2006-07       Impact factor: 3.167

Review 7.  The WHO classification of tumors of the nervous system.

Authors:  Paul Kleihues; David N Louis; Bernd W Scheithauer; Lucy B Rorke; Guido Reifenberger; Peter C Burger; Webster K Cavenee
Journal:  J Neuropathol Exp Neurol       Date:  2002-03       Impact factor: 3.685

8.  Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood.

Authors:  L B Rorke; R Packer; J Biegel
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

9.  Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor alpha receptor expression in human malignant gliomas.

Authors:  M Hermanson; K Funa; J Koopmann; D Maintz; A Waha; B Westermark; C H Heldin; O D Wiestler; D N Louis; A von Deimling; M Nistér
Journal:  Cancer Res       Date:  1996-01-01       Impact factor: 12.701

10.  Microsatellite instability and expression of DNA mismatch repair genes in malignant astrocytic tumors from adult and pediatric patients.

Authors:  M Szybka; J Bartkowiak; K Zakrzewski; L Polis; P Liberski; R Kordek
Journal:  Clin Neuropathol       Date:  2003 Jul-Aug       Impact factor: 1.368

View more
  3 in total

Review 1.  Medulloblastoma: Molecular Classification-Based Personal Therapeutics.

Authors:  Tenley C Archer; Elizabeth L Mahoney; Scott L Pomeroy
Journal:  Neurotherapeutics       Date:  2017-04       Impact factor: 7.620

Review 2.  Immunotherapy for Medulloblastoma: Current Perspectives.

Authors:  Tanvir F Kabir; Charles A Kunos; John L Villano; Aman Chauhan
Journal:  Immunotargets Ther       Date:  2020-04-20

3.  MiR-9-3p augments apoptosis induced by H2O2 through down regulation of Herpud1 in glioma.

Authors:  Ling Yang; Yongping Mu; Hongwei Cui; Yabing Liang; Xiulan Su
Journal:  PLoS One       Date:  2017-04-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.